VEGF antagonist formulations suitable for intravitreal administration

Details for Australian Patent Application No. 2012202859 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Dix, Daniel; Graham, Kenneth S.; Frye, Kelly; Furfine, Eric

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012202859

Parent 2007261536

Filing date 16 May 2012

Wipo publication date 7 June 2012

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 May 2012 Complete Application Filed

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202859

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202860-Antibodies against and methods for producing vaccines for respiratory syncytial virus

2012202858-Automated material handling system